Short Term Aggressive Mid Term Call
Buy STHINPA ( SOUTH INDIA PAPER MILLS - 516108) at CMP of 163.5 - 165
and dips till 157
Sl 153
Targets:- 170 - 172 - 175 - 178 - 181 - 185+
Above 185 we can see 200 - 220+
Disclaimer:- I am not SEBI Registered. Please consult your financial advisor before investing
Buy STHINPA ( SOUTH INDIA PAPER MILLS - 516108) at CMP of 163.5 - 165
and dips till 157
Sl 153
Targets:- 170 - 172 - 175 - 178 - 181 - 185+
Above 185 we can see 200 - 220+
Disclaimer:- I am not SEBI Registered. Please consult your financial advisor before investing
Market Wizard
Bumper Mid Term Call Buy Bhagyanagar Property at CMP of 31.9 - 32.5 and dips of 28 Sl 26 Targets:- 34 - 36 - 37.5 - 39+ Above that we can see 43 - 47 - 51+ Disclaimer:- I am not SEBI Registered. Please consult your financial advisor before investing.
ADDED MORE BHAGYANAGAR PROPERTY AGGRESSIVELY AT 31.8 - 31.85 - 31.95
Follow this link to join my WhatsApp group: https://chat.whatsapp.com/Kor9Ko2gMTZ5SDoaIWD9vM
Techno Funda Short Term Call
Buy HIMTEK (BSE - 505712) at CMP of 133 - 135 and dips till 125
Sl 117
Targets:- 140 - 143 - 147 - 151 - 155 - 160+
Above that we can see 170 - 180+
Disclaimer:- I am not SEBI Registered. Please consult your financial advisor before investing.
Buy HIMTEK (BSE - 505712) at CMP of 133 - 135 and dips till 125
Sl 117
Targets:- 140 - 143 - 147 - 151 - 155 - 160+
Above that we can see 170 - 180+
Disclaimer:- I am not SEBI Registered. Please consult your financial advisor before investing.
Market Wizard
Techno Funda Short Term Call Buy HIMTEK (BSE - 505712) at CMP of 133 - 135 and dips till 125 Sl 117 Targets:- 140 - 143 - 147 - 151 - 155 - 160+ Above that we can see 170 - 180+ Disclaimer:- I am not SEBI Registered. Please consult your financial advisor…
PERSONALLY ADDED HIMTEK AT 134.8 - 135 - 135.6 - 136
DONT MISS TO ADD HIMTEK
DONT MISS TO ADD HIMTEK
Market Wizard
PERSONALLY ADDED HIMTEK AT 134.8 - 135 - 135.6 - 136 DONT MISS TO ADD HIMTEK
DONT MISS TO ADD HIMTEK
ADDED MORE HIMTEK AGGRESSIVELY
DONT MISS TO ADD. PERSONALLY ADDED 4K HIMTEK AT AVG OF 136.22
DONT MISS TO ADD. PERSONALLY ADDED 4K HIMTEK AT AVG OF 136.22
Market Wizard
ADDED PATELSAI AT 229.05 - 231.45 - 232 - 232.5
ADDED PATELSAI AT 225.5 - 226
Market Wizard
Techno Funda Short Term Call Buy HIMTEK (BSE - 505712) at CMP of 133 - 135 and dips till 125 Sl 117 Targets:- 140 - 143 - 147 - 151 - 155 - 160+ Above that we can see 170 - 180+ Disclaimer:- I am not SEBI Registered. Please consult your financial advisor…
Screenshot of 4k Himtek Buying. Don't miss guys. ✈️✈️✈️
*Rolex Rings Limited IPO allotment will be now available on below sites...* 👇
https://www.linkintime.co.in/IPO/public-issues.html
https://linkintime.co.in/MIPO/Ipoallotment.html
https://www.linkintime.co.in/IPO/public-issues.html
https://linkintime.co.in/MIPO/Ipoallotment.html
*Caplin Point Laboratories Ltd.* | *CMP* Rs. 882 | *M Cap* Rs. 6672 Cr | *52 W H/L* 1035/391
(Nirmal Bang Retail Research)
*Result has improved*
Revenue from Operations came at Rs. 300.4 Cr (7.8% QoQ, 25.1% YoY) vs QoQ Rs. 278.7 Cr, YoY Rs. 240.1 Cr
EBIDTA came at Rs. 92.6 Cr (8.1% QoQ, 29.3% YoY) vs QoQ Rs. 85.7 Cr, YoY Rs. 71.6 Cr
EBITDA Margin came at 30.8% vs QoQ 30.7%, YoY 29.8%
Adj. PAT came at Rs. 70.9 Cr vs QoQ Rs. 66.4 Cr, YoY Rs. 54.5 Cr
Quarter EPS is Rs. 9.4
Share is trading at P/E of 22.2x FY22E EPS
(Nirmal Bang Retail Research)
*Result has improved*
Revenue from Operations came at Rs. 300.4 Cr (7.8% QoQ, 25.1% YoY) vs QoQ Rs. 278.7 Cr, YoY Rs. 240.1 Cr
EBIDTA came at Rs. 92.6 Cr (8.1% QoQ, 29.3% YoY) vs QoQ Rs. 85.7 Cr, YoY Rs. 71.6 Cr
EBITDA Margin came at 30.8% vs QoQ 30.7%, YoY 29.8%
Adj. PAT came at Rs. 70.9 Cr vs QoQ Rs. 66.4 Cr, YoY Rs. 54.5 Cr
Quarter EPS is Rs. 9.4
Share is trading at P/E of 22.2x FY22E EPS
*Cera Sanitaryware Ltd.* | *CMP* Rs. 4524 | *M Cap* Rs. 5884 Cr | *52 W H/L* 4895/2100
(Nirmal Bang Retail Research)
*Result is below expectations*
Revenue from Operations came at Rs. 228.2 Cr (-47.9% QoQ, 56.3% YoY) vs expectation of Rs. 281.9 Cr, QoQ Rs. 438.4 Cr, YoY Rs. 146 Cr
EBIDTA came at Rs. 20.8 Cr (-70.3% QoQ, 450.3% YoY) vs expectation of Rs. 35.9 Cr, QoQ Rs. 70.1 Cr, YoY Rs. 3.8 Cr
EBITDA Margin came at 9.1% vs expectation of 12.7%, QoQ 16%, YoY 2.6%
Adj. PAT came at Rs. 12.2 Cr vs expectation of Rs. 22.4 Cr, QoQ Rs. 45.8 Cr, YoY Rs. 0.5 Cr
Quarter EPS is Rs. 9.4
Share is trading at P/E of 39.8x FY22E EPS
(Nirmal Bang Retail Research)
*Result is below expectations*
Revenue from Operations came at Rs. 228.2 Cr (-47.9% QoQ, 56.3% YoY) vs expectation of Rs. 281.9 Cr, QoQ Rs. 438.4 Cr, YoY Rs. 146 Cr
EBIDTA came at Rs. 20.8 Cr (-70.3% QoQ, 450.3% YoY) vs expectation of Rs. 35.9 Cr, QoQ Rs. 70.1 Cr, YoY Rs. 3.8 Cr
EBITDA Margin came at 9.1% vs expectation of 12.7%, QoQ 16%, YoY 2.6%
Adj. PAT came at Rs. 12.2 Cr vs expectation of Rs. 22.4 Cr, QoQ Rs. 45.8 Cr, YoY Rs. 0.5 Cr
Quarter EPS is Rs. 9.4
Share is trading at P/E of 39.8x FY22E EPS
*Ipca Laboratories Ltd.* | *CMP* Rs. 2065 | *M Cap* Rs. 26195 Cr | *52 W H/L* 2460/1715
(Nirmal Bang Retail Research)
*Result is above expectations*
Revenue from Operations came at Rs. 1565.8 Cr (40.5% QoQ, 2% YoY) vs expectation of Rs. 1387.8 Cr, QoQ Rs. 1114.7 Cr, YoY Rs. 1534.4 Cr
EBIDTA came at Rs. 416.5 Cr (82% QoQ, -29.2% YoY) vs expectation of Rs. 353.4 Cr, QoQ Rs. 228.9 Cr, YoY Rs. 588.3 Cr
EBITDA Margin came at 26.6% vs expectation of 25.5%, QoQ 20.5%, YoY 38.3%
Adj. PAT came at Rs. 306.7 Cr vs expectation of Rs. 253.4 Cr, QoQ Rs. 161.3 Cr, YoY Rs. 446.1 Cr
Quarter EPS is Rs. 24.2
Share is trading at P/E of 23.7x FY22E EPS
(Nirmal Bang Retail Research)
*Result is above expectations*
Revenue from Operations came at Rs. 1565.8 Cr (40.5% QoQ, 2% YoY) vs expectation of Rs. 1387.8 Cr, QoQ Rs. 1114.7 Cr, YoY Rs. 1534.4 Cr
EBIDTA came at Rs. 416.5 Cr (82% QoQ, -29.2% YoY) vs expectation of Rs. 353.4 Cr, QoQ Rs. 228.9 Cr, YoY Rs. 588.3 Cr
EBITDA Margin came at 26.6% vs expectation of 25.5%, QoQ 20.5%, YoY 38.3%
Adj. PAT came at Rs. 306.7 Cr vs expectation of Rs. 253.4 Cr, QoQ Rs. 161.3 Cr, YoY Rs. 446.1 Cr
Quarter EPS is Rs. 24.2
Share is trading at P/E of 23.7x FY22E EPS
Sonata Software
(Nirmal Bang Retail Research )
*Outlook – Positive*
• Q2 company will have Acquisition impact
• International IT services Revenue for the quarter came at $44.5 mn (+1.1% QoQ, 21.9% YoY). Ebitda margin excl forex came at 21.3% vs QoQ 22.4% .With demand promising Management guides of growing this vertical to grow by 3- 4 % QoQ on organic basis going ahead
• Domestic business revenue for the quarter came at Rs 324 cr(+1.5% QoQ, +25.5% YoY). Ebitda margin came at 25% vs QoQ 26%. Management indicates of growing absoulte EBitda on domestic business by 4-5%. Revenue growth is expected to inline with EBitda growth
• Supply side headwind with covid and falling sick not able to do work led to attrition higher then normal . Supply side issue management is addressing this issue and is expected to improve in in comig qtrs.
• Demand looks robust better for next 2 qtrs
• On vertical front , Travel vertical grew by 2.1% QoQ. Looking at Deal flow from travel vertical, this verticals looks promising
• Employees for the qtr stood at 4250
• Share is trading at 20.9x FY23E EPS
(Nirmal Bang Retail Research )
*Outlook – Positive*
• Q2 company will have Acquisition impact
• International IT services Revenue for the quarter came at $44.5 mn (+1.1% QoQ, 21.9% YoY). Ebitda margin excl forex came at 21.3% vs QoQ 22.4% .With demand promising Management guides of growing this vertical to grow by 3- 4 % QoQ on organic basis going ahead
• Domestic business revenue for the quarter came at Rs 324 cr(+1.5% QoQ, +25.5% YoY). Ebitda margin came at 25% vs QoQ 26%. Management indicates of growing absoulte EBitda on domestic business by 4-5%. Revenue growth is expected to inline with EBitda growth
• Supply side headwind with covid and falling sick not able to do work led to attrition higher then normal . Supply side issue management is addressing this issue and is expected to improve in in comig qtrs.
• Demand looks robust better for next 2 qtrs
• On vertical front , Travel vertical grew by 2.1% QoQ. Looking at Deal flow from travel vertical, this verticals looks promising
• Employees for the qtr stood at 4250
• Share is trading at 20.9x FY23E EPS